Journal of Clinical Densitometry
Volume 13, Issue 1 , Pages 36-42 , January 2010

How Activity of Inflammatory Bowel Disease Influences Bone Loss

  • Zeljka Crncevic Orlic

      Affiliations

    • Department of Endocrinology, Diabetes and Metabolic Diseases, Clinical Hospital Centre Rijeka, Rijeka, Croatia
    • Corresponding Author InformationAddress correspondence to: Zeljka Crncevic Orlic, M.D., Ph.D., Endocrinology Department, Clinic of Internal Medicine, University Hospital Rijeka, KBC Rijeka, Kresimirova 42, 51000 Rijeka, Croatia, Europe.
    • ,
  • Tamara Turk

      Affiliations

    • Department of Endocrinology, Diabetes and Metabolic Diseases, Clinical Hospital Centre Rijeka, Rijeka, Croatia
    • ,
  • Brankica Mijandrusic Sincic

      Affiliations

    • Department of Gastroenterology, Clinical Hospital Centre Rijeka, Rijeka, Croatia
    • ,
  • Davor Stimac

      Affiliations

    • Department of Gastroenterology, Clinical Hospital Centre Rijeka, Rijeka, Croatia
    • ,
  • Olga Cvijanovic

      Affiliations

    • Department of Anatomy, Medical School, University of Rijeka, Rijeka, Croatia
    • ,
  • Ivana Maric

      Affiliations

    • Department of Anatomy, Medical School, University of Rijeka, Rijeka, Croatia
    • ,
  • Maja Ilic Tomas

      Affiliations

    • Department of Physiology and Immunology, University of Rijeka, Rijeka, Croatia
    • ,
  • Dubravka Jurisic-Erzen

      Affiliations

    • Department of Endocrinology, Diabetes and Metabolic Diseases, Clinical Hospital Centre Rijeka, Rijeka, Croatia
    • ,
  • Vanja Licul

      Affiliations

    • Department of Gastroenterology, Clinical Hospital Centre Rijeka, Rijeka, Croatia
    • ,
  • Dragica Bobinac

      Affiliations

    • Department of Anatomy, Medical School, University of Rijeka, Rijeka, Croatia

Received 22 March 2009 ,Revised 9 December 2009 ,Accepted 10 December 2009.

References 

  1. Bernstein CN, Leslie WD, LeBoff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795–841
  2. Bernstein CN, Leslie WD. Review article: osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;19:941–952
  3. Bischoff SC, Herrmann A, Goke M, et al. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol. 1997;92:1157–1163
  4. Williams CN, Bursey RF, Gall DG, et al. Trends in IBD therapy. Dordrecht, The Netherlands: Kluner Academic Publishers; 1999;147–162
  5. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology. 1994;107:1031–1039
  6. Lichtenstein GR. Evaluation of bone mineral density in IBD: current safety focus. Am J Gastroenterol. 2003;98(Suppl 12):S24–S30
  7. Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis. Gut. 1997;40:313–319
  8. Ardizzone S, Bollani S, Bettica P, et al. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med. 2000;247:63–70
  9. Bernstein CN, Seeger LL, Sayre JW, et al. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res. 1995;10:250–256
  10. Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology. 1995;108:417–422
  11. Valentine JF, Sninsky CA. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol. 1999;94(4):878–883
  12. Pollak RD, Karmeli F, Eliakim R, et al. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998;93:1483–1490
  13. Silvennoinen JA, Karttunen TJ, Niemela SE, et al. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 1995;37:71–76
  14. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24(Suppl 170):2–6
  15. Best WR, Becktel JM, Singleton JW, Kern F. Development of Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439–444
  16. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J. 1955;4947:1041–1048
  17. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1–129Available online at http://apps.who.int
  18. Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000;133:795–799
  19. Bjarnason I, Macpherson A, Mackintosh C, et al. Reduced bone density in patients with inflammatory bowel disease. Gut. 1997;40:228–233
  20. Robinson RJ, al-Azzawi F, Iqbal SJ, et al. Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci. 1998;43:2500–2506
  21. Schoon EJ, van Nunen AB, Wouters RS, et al. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. Scand J Gastroenterol. 2000;35(Suppl 232):43–47
  22. Papaioannou A, Ferko NC, Adachi JD. All patients with inflammatory bowel disease should have bone density assessment: pro. Inflamm Bowel Dis. 2001;7:158–162discussion 168–169
  23. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal disease. Gastroenterology. 2003;124:791–794Available online at http://www.gastro.org
  24. Kornbluth A, Hayes M, Feldman S, et al. Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria. Am J Gastroenterol. 2006;101:1546–1550
  25. Robinson RJ, al-Azzawi F, Iqbal SJ, et al. The relation of hand skin-fold thickness to bone mineral density in patients with Crohn's disease. Eur J Gastroenterol Hepatol. 1997;9:945–949
  26. Schulte C, Dignass AU, Mann K, Goebell H. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis. 1998;4:268–275
  27. Andreassen H, Hylander E, Rix M. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients. Am J Gastroenterol. 1999;94:824–828
  28. Ulivieri FM, Piodi LP, Taioli E, et al. Bone mineral density and body composition in ulcerative colitis: a six-year follow-up. Osteoporos Int. 2001;12:343–348
  29. Motley RJ, Crawley EO, Evans C, et al. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut. 1988;29:1332–1336
  30. Tromm A, Rickels K, Huppe D, et al. Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography, Leber Magen Darm. 1994;24:23–2629–30
  31. Raisz LG. Clinical practice. Screening for osteoporosis. N Engl J Med. 2005;14(353):164–171
  32. van Hogezand RA, Hamdy NA. Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol. 2006;41(Suppl 243):59–64
  33. Leslie WD. All patients with inflammatory bowel disease should have bone density assessment: con. Inflamm Bowel Dis. 2001;7:163–169
  34. Dresner-Pollak R, Karmeli F, Eliakim R, et al. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol. 2000;95:699–704
  35. Dinca M, Fries W, Luisetto G, et al. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol. 1999;94:1292–1297
  36. Sinnott BP, Licata AA. Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review. Endocr Pract. 2006;12:622–629
  37. Alesci S, De Martino MU, Ilias I, et al. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects. Neuroimmunomodulation. 2005;12:1–19
  38. Shaker JL, Lukert BP. Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am. 2005;34:341–356
  39. van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology. 2000;39:1383–1389
  40. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13:777–787
  41. Kanis JA, Johnell O, Gullberg B, et al. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ. 1992;305:1124–1128
  42. Sapone N, Pellicano R, Simondi D, et al. A 2008 panorama on osteoporosis and inflammatory bowel disease. Minerva Med. 2008;99:65–71
  43. Rodríguez-Bores L, Barahona-Garrido J, Yamamoto-Furusho JK. Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol. 2007;13:6156–6165
  44. Sylvester FA, Wyzga N, Hyams JS, et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:42–50
  45. Reffitt DM, Meenan J, Sanderson JD, et al. Bone density improves with disease remission in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2003;15:1267–1273
  46. Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol. 2009;15:2570–2578

PII: S1094-6950(09)00271-6

doi: 10.1016/j.jocd.2009.12.002

Journal of Clinical Densitometry
Volume 13, Issue 1 , Pages 36-42 , January 2010

Article Tools

* Image Usage & Resolution